v3.25.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (9,045,827) $ (9,418,585)
Net loss from discontinuing operations (2,748,049) (2,943,227)
Net loss from continuing operations (6,297,778) (6,475,358)
Adjustments to reconcile net loss to net cash from operating activities:    
Depreciation and amortization 139,182 403,593
Interest expense - OID 640,000
Share based compensation 35,415 83,031
Loss on disposition of assets 1,475,289
Loss on impairment 3,519,322
Bad debt expense 431,671
Gain on extinguishment of debt (94,346)
Changes in operating assets and liabilities:    
Accounts receivable, net (28,030) 1,449,569
Prepaid expenses and other current assets 33,360 265,553
Deferred compensation 196,121
Security deposits 205,389
Liability to issue common stock (329,855)
Right of use/lease liability (346,770)
Accounts payable and accrued expenses 5,063,810 (388,467)
Patient deposits (241,666)
Net cash used in operating activities from continuing operations (414,041) 153,076
Net cash used in operating activities from discontinued operations (2,748,049) (2,943,227)
Net cash used in operating activities (3,162,090) (2,790,151)
Cash flows from investing activities:    
Purchase of property and equipment
Note receivable (375,000) (3,000,000)
Proceeds from sale of practices 224,700
Proceeds from sale of property and equipment 1,000,000
Net cash used in investing activities (375,000) (1,775,300)
Cash flows from financing activities:    
Proceeds from issuance of common stock 16,650
Proceeds from issuance of preferred stock, net of offering costs 2,221,492 4,045,000
Payments on notes payable (10,350)
Proceeds from notes payable 1,600,000
Payments on finance lease obligation (1,724) (27,549)
Net cash from financing activities 3,819,768 4,023,751
Net increase (decrease) in cash 282,678 (541,700)
Cash, beginning of year 221,511 763,211
Cash, end of year 504,189 221,511
Supplemental cash flow information:    
Interest paid 129,981
Income Tax
Non-cash investing and financial activities:    
Preferred stock conversion 2
Converted accrued C-1 dividends 29,000
Preferred dividends accrued – C-1 & C-2 306,000
Preferred dividends accrued – B-1 88,000 130,000
Preferred dividends accrued converted into C-1 (218,000)
Capitalized dividends – D, E, F & G 2,738,000
Settlement of notes receivable in connection with asset purchase agreement $ 1,044,000